Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma: Clinical and Model-Based Analyses

Neeraj Gupta, Huyuan Yang, Michael J. Hanley, Steven Zhang, Rachael Liu, Shaji Kumar, Paul G. Richardson, Tomas Skacel, Karthik Venkatakrishnan

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma: Clinical and Model-Based Analyses'. Together they form a unique fingerprint.

Medicine & Life Sciences